Is it time to abandon functional imaging in the study of neuroprotection?
- 6 February 2002
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 17 (2) , 229-232
- https://doi.org/10.1002/mds.10112
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pramipexole vs Levodopa as Initial Treatment for Parkinson DiseaseJAMA, 2000
- Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET studyBrain, 1999
- Getting oriented to patient-oriented outcomesNeurology, 1999
- Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PETJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's diseaseAnnals of Neurology, 1995
- Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levelsAnnals of Neurology, 1993